Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Research Tree provides access to ongoing research coverage, media content and regulatory news on BEAR OBX X3 HA. We currently have 0 research reports from 0 professional analysts.
Companies: Jet2 PLC
Canaccord Genuity
Companies: Carclo plc
Panmure Liberum
For two years running, the Hardman & Co Healthcare index has declined, underperforming both the FTSE 100 and the FTSE All-Share indices. This is quite unusual for healthcare stocks. Apart from the general economic influences, which have made institutions more risk-averse, there was a common knowledge that several companies were in need of additional working capital; so, share prices were marked down in anticipation of equity raises. However, the small- and mid-cap life sciences sector has alway
Companies: NCYT SN/ GSK AZN AGY GDR TRX CTEC RENE ONT SLN IMCR
Hardman & Co
Companies: CC Japan Income And Growth Trust
Kepler | Trust Intelligence
Our analysts review how their fund picks for 2024 have done…
Companies: NBPE BUT BASC SHRS ESCT RKW CCJI BBH
Elixirr offers investors exposure to the long-term growth trends in the global Consulting market (including digitisation and the ongoing technology revolution, demand for innovation, efficiency and specialised expertise) all turbo charged by the group’s ‘challenger’ strategy driving market share gain from a low base. FY 2023 results showed the power of Elixirr’s differentiated model with revenue up +20% and adj. EPS up +22% in a market subdued by global uncertainty. With net cash of £18m, a posi
Companies: Elixirr International Plc
Cavendish
Companies: FRP STX GELN
Gym Group has accompanied confirmation of FY23 profit resilience and continued buoyancy (like-for-like revenue up 12% in the first two months of 2024) with a clear commitment ‘to accelerate, not reinvent the wheel.’ The latter is telling with new senior management endorsing Gym Group’s sweet spot as a low-cost operator in the long-term growth market of health and fitness. Its confidence in material scope for enhanced pricing and member acquisition and retention is complemented by expansion targe
Companies: Gym Group Plc
Edison
The focus of Hardman & Co Research is on the nine quoted Infrastructure Investment Companies (IICs) and on the 22 Renewable Energy Infrastructure Funds (REIFs): the stocks analysed are all members of the Association of Investment Companies (AIC). We are updating our publication of January 2023, assessing both the lacklustre share price performances during 2023 and the key issues, including interest rates, inflation and power prices. As a 31-strong group, its combined market capitalisation is no
Companies: AEIT ROOF DGI9 INPP GSF SEIT USFP HICL ORIT BSIF TRIG NESF SEQI HEIT GRP GCP FSFL 3IN AERI PINT RNEW BBGI GSEO DORE TENT GRID CORD HGEN AEET
In a volatile period for stock markets, the UK industrial sector has continued its steady improved performance. Manufacturing PMI data reached a two-year high of 52.1 in July with optimism reaching the second-highest level in the survey this year. Inflation remained at 2.0% in June which, coupled with promising labour market data, led the MPC to reduce the base rate by 25bps to 5.0%. Although challenges such as supply chain disruption and economic volatility still remain, the sector’s improving
Companies: TAND AVON BMTO CGS GHH PEN SCE RCDO SOLI TRI SYM IGE JDG PEG CSSG ABDP PODP KETL LIFS SPSY
Zeus Capital
Companies: Begbies Traynor Group plc
Companies: Mattioli Woods plc
What you need to know: • Since our last note in May, there have been 10 additional takeouts in Canadian small-caps, most of which coming in a significant premiums. • The new acquisitions largely fit within the framework outlined in previous reports. • Our potential takeouts portfolio is up 43% since inception (November 2023) and 17% since our last note, compared to the TSX up 18% and 3% respectively. We review the biggest winners and losers in the portfolio and present a list of new ideas on ou
Companies: GSI KUT IFX QIS HAI DRX BQE GCL COV CTX GSI IFX PNG MAL OSS QIS KUT GRID SYZ COV XYBN ETOLF
Atrium Research
Time has released its FY24E trading update which shows revenue and PBT coming in ahead of expectations at £33m (Cavendish forecast: £31.5m) and £5.8m (Cavendish forecast: £5.7m), respectively. The trading update gives us confidence to upgrade our forecasts for FY25E, resulting in a 10% increase in basic EPS. The Group’s gross book has hit the record milestone of £200m and is on track to hit its 4-year target of doubling the book to over £230m by the end of FY25E. It continues to grow EPS at over
Companies: Time Finance plc
Companies: 88E CRU MPE RUA NXQ SWG FRP
